STAT+: Pharmalittle: Medicare is poised to negotiate drug prices; Pfizer to pay $5.4 billion for Global Blood Therapeutics

Soon, Medicare will be able to use the full brunt of its leverage to negotiate discounts from drugmakers, like the governments in many other high-income countries.

Click to view original post